These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16854681)

  • 1. Pre-malignant and malignant cervical pathologies among inert and copper-bearing intrauterine contraceptive device users: a 10-year follow-up study.
    Ganacharya S; Bhattoa HP; Batár I
    Eur J Contracept Reprod Health Care; 2006 Jun; 11(2):89-97. PubMed ID: 16854681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Szontágh IUD and cervix carcinoma (results of a 10-year follow up study)].
    Batár I
    Orv Hetil; 1990 Aug; 131(34):1871-4. PubMed ID: 2204867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up.
    Eroğlu K; Akkuzu G; Vural G; Dilbaz B; Akin A; Taşkin L; Haberal A
    Contraception; 2006 Nov; 74(5):376-81. PubMed ID: 17046378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic pregnancy among non-medicated and copper-containing intrauterine device users: a 10-year follow-up.
    Ganacharya S; Bhattoa HP; Batár I
    Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):78-82. PubMed ID: 14557017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Random comparative study between intrauterine device Multiload Cu375 and TCu 380a inserted in the postpartum period].
    Lara Ricalde R; Menocal Tobías G; Ramos Pérez C; Velázquez Ramírez N
    Ginecol Obstet Mex; 2006 Jun; 74(6):306-11. PubMed ID: 16970116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim insertion of the ML Cu 250 intrauterine contraceptive device.
    Vankets He Thiery M; Van Der Pas H; Delbeke L Van Os WA; Tauber PE; Dombrowicz N; Macdonald JS; Haspels AA; Drogenduk AC
    Contracept Deliv Syst; 1980 Apr; 1(2):149-54. PubMed ID: 12336242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R; Knight I; Keane F
    Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital mycoplasma in intrauterine contraceptive device users.
    Gupta I; Sharma S; Ganguli NK; Devi PK
    Indian J Pathol Microbiol; 1979 Jul; 22(3):235-8. PubMed ID: 544494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess.
    Charonis G; Larsson PG
    Acta Obstet Gynecol Scand; 2009; 88(6):680-4. PubMed ID: 19412803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actinomyces in cervical smears of women using the intrauterine device in Singapore.
    Kalaichelvan V; Maw AA; Singh K
    Contraception; 2006 Apr; 73(4):352-5. PubMed ID: 16531165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic monitoring of women using copper-containing intrauterine devices: five-year follow-up study.
    Luthra UK; Mitra AB; Prabhakar AK; Agarwal SS; Bhatnagar P
    Acta Cytol; 1982; 26(5):619-22. PubMed ID: 6959449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicentre comparative clinical study of uterine cavity shaped device Cu300, TCu220C and TCu380A in ten years].
    Chen HP; Liu F; Wu SC; Zou MH; Tong ZJ; Song S; Cheng WY; Wang SZ; Pan QR
    Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):298-301. PubMed ID: 12895316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time ultrasound in locating intrauterine contraceptive devices.
    Nelson LH; Miller JB
    Obstet Gynecol; 1979 Dec; 54(6):711-4. PubMed ID: 514557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the intrauterine contraceptive device in adolescents.
    Toma A; Jamieson MA
    J Pediatr Adolesc Gynecol; 2006 Aug; 19(4):291-6. PubMed ID: 16873034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices.
    Celen S; Möröy P; Sucak A; Aktulay A; Danişman N
    Contraception; 2004 Apr; 69(4):279-82. PubMed ID: 15033401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs.
    Haugan T; Skjeldestad FE; Halvorsen LE; Kahn H
    Contraception; 2007 Mar; 75(3):171-6. PubMed ID: 17303485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the complications of 2 copper intrauterine devices: T380A and Cu-Safe 300.
    Nahidi F; Jalalinia S
    East Mediterr Health J; 2008; 14(1):95-102. PubMed ID: 18557456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.